Efficacy and side effect profile of two CMV prophylaxis strategies in high and intermediate risk kidney transplant recipients – a multicentre national study

2021 ◽  
Author(s):  
Trijntje J. W. Rennie ◽  
Colin G. Geddes ◽  
Rhianna McIntyre-McClure ◽  
Bernadine H. E. Chua ◽  
Wendy Metcalfe ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Side Effect ◽  
National Study ◽  
Intermediate Risk ◽  
Side Effect Profile ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cmv Prophylaxis

scholarly journals Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients

2020 ◽  
Author(s):  
Joanna Schaenman ◽  
Korntip Phonphok ◽  
Ittikorn Spanuchart ◽  
Tin Duong ◽  
Theodore M. Sievers ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Dose Adjustment ◽  
Intermediate Risk ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

scholarly journals Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study

2021 ◽  
Vol 7 (8) ◽  
pp. e736
Author(s):  
Ngan N. Lam ◽  
Rachel Jeong ◽  
Robert R. Quinn ◽  
Pietro Ravani ◽  
Huiling Xiao ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Antithymocyte Globulin ◽  
National Study ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Clinical Correlates

Evaluation of cytomegalovirus prophylaxis in low and intermediate risk kidney transplant recipients receiving lymphocyte‐depleting induction

2021 ◽  
Author(s):  
Hillary Stamps ◽  
Kristin Linder ◽  
David M. O'Sullivan ◽  
Oscar K. Serrano ◽  
Caroline Rochon ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Intermediate Risk ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document